Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas

Publication
Article
Supplements and Featured PublicationsDiagnosis and Trial Options in Sarcoma
Volume 1
Issue 1

Articles in this issue
Javier Martin-Broto, MD, PhD,
Dr. Martin-Broto on Future Research Directions of Soft Tissue Sarcoma
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Jean-Yves Blay, MD
Dr. Blay on Treatment Considerations in Soft Tissue Sarcomas
Patricia LoRusso, DO
Dr. LoRusso on the Benefit of Genetic Sequencing in Sarcomas
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on the Current First-Line Treatment of Soft Tissue Sarcomas
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on MDM2 and P53 in Soft Tissue Sarcoma
Javier Martin-Broto, MD, PhD
Dr. Martin-Broto on the Ongoing Research of MDM2 Agonists in Soft Tissue Sarcoma
Patricia LoRusso, DO
MDM2 Pulls Novel Treatments Into Focus for Underserved Liposarcoma Population
Patricia LoRusso, DO
Dr. LoRusso on the Importance of Clinical Trials in MDM2-Amplified Dedifferentiated Liposarcoma
Jean-Yves Blay, MD
Dr. Blay on the Current Treatment Challenges in Soft Tissue Sarcomas
Patricia LoRusso, DO
Dr. LoRusso on the Efficacy of BI 907828 in Solid Tumors
Jean-Yves Blay, MD
Dr. Blay on the Exploration of BI 907828 in Patients With Sarcoma
Related Videos
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Sundar Jagannath, MBBS
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
Elias Jabbour, MD
Rebecca Klisovic, MD
Axel Hauschild, MD, PhD, head, Skin Cancer Trial Center, University Hospital Schleswig-Holstein
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Jubilee Brown, MD
Changchun Deng, MD, PhD
A panel of 4 experts on colorectal cancer
Related Content
Anthony M. Hunter, MD

Novel Targets Beyond the JAK-STAT Pathway Aim to Push Myelofibrosis Treatment Forward

May 10th 2024
Article
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, professor, division head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; codirector, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors

May 9th 2024
Podcast
Breast Cancer - stock.adobe.com

Fuzuloparib ± Apatinib Significantly Boosts PFS in BRCA+ HER2– Metastatic Breast Cancer

May 9th 2024
Article
Andre H. Goy, MD, vice president, physician in chief, Oncology Care Transformation Services, chairman, chief physician officer, chief, Lymphoma Division, John Theurer Cancer Center at Hackensack University Medical Center; Lydia Pfund Chair for Lymphoma, academic chairman, Oncology, Hackensack Meridian School of Medicine; professor, medicine, Georgetown University

Goy Gives Insights Into the Future Management of Lymphoma and Multiple Myeloma

May 6th 2024
Podcast
John Ebos, PhD, of Roswell Park Comprehensive Cancer Center

New Evidence Explains Why Some Targeted Therapies Support Better Response to Cancer Immunotherapy

May 9th 2024
Article
Gursel Aktan, MD, vice president, global clinical development, Merck Research Laboratories

Adjuvant Pembrolizumab/Chemo Misses Primary End Point of DFS in High-Risk Endometrial Cancer

May 9th 2024
Article